Saturday, October 17, 2026 · Edition updated 6:00 AM ETSAT, OCT 17 · 6 AM ET editionNext edition in Next --:--:--

Ciprofloxacin made human skin cells in a dish look older

A study · International journal of molecular sciences · Oct 16, 2026

What this means

Researchers exposed cells in a dish to three antibiotics and only ciprofloxacin caused aging-like changes. Antioxidants reduced these changes, but this does not show what happens in people.

Plain-English summary written by an AI model from the abstract. The original is below.

Tested inCells in a lab
Who it was tested in
Human fibroblasts (skin-type cells) grown in a lab dish
Kind of research
A study

The science

Original title
Ciprofloxacin-Induced Oxidative Stress Promotes a Senescence-like Phenotype in Human Fibroblasts In Vitro.
Authors
Kondratenko ND, Chelombitko MA, Zinovkina LA et al.
Journal
International journal of molecular sciences
Published
Oct 16, 2026
Study type
Study · in humans

Abstract

Fluoroquinolones are effective synthetic broad-spectrum antibiotics, but their use can be associated with persistent adverse effects, sometimes described as fluoroquinolone-induced disability. The molecular mechanisms underlying these effects remain incompletely understood, although accumulating evidence implicates mitochondrial dysfunction, oxidative stress, and DNA damage. We hypothesized that the convergence of these stress responses may promote cellular senescence and thereby contribute to persistent fluoroquinolone-associated adverse effects. We examined three clinically used fluoroquinolones-ciprofloxacin, moxifloxacin, and levofloxacin-in primary human fibroblasts in vitro. Exposure for 7 days revealed that 200 µM ciprofloxacin, but not 200 µM moxifloxacin or 500 µM levofloxacin, induced a senescence-like phenotype characterized by increased senescence-associated β-galactosidase (SA-β-Gal) activity and an elevated senescence index (SI), which integrates increased cell size and autofluorescence measured by imaging flow cytometry. At 7 days, ciprofloxacin did not induce a broad canonical senescence-associated secretory phenotype (SASP) at either the transcriptional or secretory level, consistent with a non-canonical senescence-like state; only a modest increase in IL-1β secretion emerged after 14 days. The ciprofloxacin-induced phenotype was not accompanied by a robust increase in the canonical p53, p16, or p21 protein markers, but was associated with reduced retinoblastoma protein (RB) phosphorylation at Ser795. However, ciprofloxacin removal from the culture medium after 1 or 2 weeks of incubation resulted in the recovery of the resazurin signal to approximately control values by the end of the 3-week experimental period. Ciprofloxacin also increased oxidative stress, as assessed using dihydroethidium and dichlorodihydrofluorescein diacetate. Both the antioxidant Trolox and the mitochondria-targeted antioxidant SkQ3 attenuated the ciprofloxacin-induced increase in SA-β-Gal activity and SI. These findings identify oxidative stress as a putative mediator of ciprofloxacin-induced senescence-like remodeling in human fibroblasts and support further investigation of drug-induced cellular senescence as a potential contributor to persistent fluoroquinolone-associated adverse effects.

Read it on PubMed ↗

Kondratenko ND, Chelombitko MA, Zinovkina LA et al. Ciprofloxacin-Induced Oxidative Stress Promotes a Senescence-like Phenotype in Human Fibroblasts In Vitro. International journal of molecular sciences. 2026. doi:10.3390/ijms27198696. PMID: 42883941. https://pubmed.ncbi.nlm.nih.gov/42883941/

Report a problem